GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Price-to-Tangible-Book

Minapharm Pharmaceuticals (CAI:MIPH) Price-to-Tangible-Book : 0.65 (As of Sep. 21, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-09-21), Minapharm Pharmaceuticals's share price is E£159.95. Minapharm Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was E£245.75. Hence, Minapharm Pharmaceuticals's Price to Tangible Book Ratio of today is 0.65.

The historical rank and industry rank for Minapharm Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

CAI:MIPH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.65   Med: 0.79   Max: 0.89
Current: 0.65

During the past 2 years, Minapharm Pharmaceuticals's highest Price to Tangible Book Ratio was 0.89. The lowest was 0.65. And the median was 0.79.

CAI:MIPH's Price-to-Tangible-Book is ranked better than
93.15% of 847 companies
in the Drug Manufacturers industry
Industry Median: 2.26 vs CAI:MIPH: 0.65

A closely related ratio is called PB Ratio. As of today, Minapharm Pharmaceuticals's share price is E£159.95. Minapharm Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was E£278.42. Hence, Minapharm Pharmaceuticals's P/B Ratio of today is 0.57.


Minapharm Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Minapharm Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Price-to-Tangible-Book Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
Price-to-Tangible-Book
0.69 0.89

Minapharm Pharmaceuticals Semi-Annual Data
Dec22 Dec23
Price-to-Tangible-Book 0.69 0.89

Competitive Comparison of Minapharm Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minapharm Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's Price-to-Tangible-Book falls into.



Minapharm Pharmaceuticals Price-to-Tangible-Book Calculation

Minapharm Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=159.95/245.75
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Minapharm Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines